David D Deininger

USPTO Granted Patents = 36 (Patent Applications = 5)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 5.4

ph-index = 13

Forward Citations = 583(Granted Patents)

Location History:

New Brunswick, NJ (US) (1991)
Cambridge, MA (US) (2001)
Arlington, MA (US) (1991 - 2012)
Waltham, MA (US) (2010 - 2013)
Boston, MA (US) (2021 - 2023)

Company Filing History:

29 out of 1,149

Vertex Pharmaceuticals, Inc.

patents

6 out of 1,567

American Home Products Corporation

Years Active: 1991-2025

Loading Chart...

36 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12384790 - Pteridinone compounds and uses thereof (2025-08-12),

2. 11572364 - Pteridinone compounds and uses thereof (2023-02-07),

3. 11059826 - Pteridinone compounds and uses thereof (2021-07-13),

4. 8536136 - Inhibitors of serine proteases, particularly HCV NS3-NS4A protease (2013-09-17),

5. 8481538 - Heterocyclic inhibitors of c-Met and uses thereof (2013-07-09),

6. 8426426 - Gyrase inhibitors and uses thereof (2013-04-23),

7. 8404852 - Gyrase inhibitors and uses thereof (2013-03-26),

8. 8394803 - Gyrase inhibitors and uses thereof (2013-03-12),

9. 8314141 - Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease (2012-11-20),

10. 8232406 - c-MET protein kinase inhibitors (2012-07-31),

11. 8193352 - Gyrase inhibitors and uses thereof (2012-06-05),

12. 8188095 - Gyrase inhibitors and uses thereof (2012-05-29),

13. 8067606 - Gyrase inhibitors and uses thereof (2011-11-29),

14. 8034832 - Gyrase inhibitors and uses thereof (2011-10-11),

15. 7998987 - Inhibitors of c-Met and uses thereof (2011-08-16),

Title: Spotlight on Inventor David D Deininger: Paving the Way in Pharmaceutical Innovations

Introduction:

David D Deininger is a prolific inventor based in Arlington, MA, with an impressive portfolio of 35 patents to his name. His groundbreaking work in the field of pharmaceuticals has earned him recognition for his contributions to treating cellular proliferative disorders, such as cancer.

Latest Patents:

Among his latest patents is the invention of Pteridinone compounds and their uses in pharmaceutical compositions for treating cellular proliferative disorders. These compounds, represented by Formula I, have shown great promise in the fight against cancer, showcasing Deininger's commitment to advancing medical research.

Career Highlights:

Deininger's innovative spirit has led him to work with esteemed companies in the pharmaceutical industry, including Vertex Pharmaceuticals, Inc. and American Home Products Corporation. His tenure at these organizations has been marked by a dedication to pushing the boundaries of science and developing novel solutions for complex medical challenges.

Collaborations:

Throughout his career, Deininger has collaborated with top-tier professionals in the field, such as Dean P Stamos and Paul S Charifson. Together, they have leveraged their collective expertise to drive forward cutting-edge research and develop new approaches to combating disease.

Conclusion:

In conclusion, David D Deininger stands out as a pioneering inventor who continues to make significant strides in the pharmaceutical sector. His relentless pursuit of innovation and his collaborative efforts underscore his commitment to improving healthcare outcomes and shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.